Literature DB >> 21593379

Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis.

Emanuela M Bruscia1, Ping-Xia Zhang, Ayano Satoh, Christina Caputo, Ruslan Medzhitov, Ambika Shenoy, Marie E Egan, Diane S Krause.   

Abstract

Morbidity and mortality in cystic fibrosis (CF) are due not only to abnormal epithelial cell function, but also to an abnormal immune response. We have shown previously that macrophages lacking CF transmembrane conductance regulator (CFTR), the gene mutated in CF, contribute significantly to the hyperinflammatory response observed in CF. In this study, we show that lack of functional CFTR in murine macrophages causes abnormal TLR4 subcellular localization. Upon LPS stimulation, CFTR macrophages have prolonged TLR4 retention in the early endosome and reduced translocation into the lysosomal compartment. This abnormal TLR4 trafficking leads to increased LPS-induced activation of the NF-κB, MAPK, and IFN regulatory factor-3 pathways and decreased TLR4 degradation, which affects downregulation of the proinflammatory state. In addition to primary murine cells, mononuclear cells isolated from CF patients demonstrate similar defects in response to LPS. Moreover, specific inhibition of CFTR function induces abnormal TLR4 trafficking and enhances the inflammatory response of wild-type murine cells to LPS. Thus, functional CFTR in macrophages influences TLR4 spatial and temporal localization and perturbs LPS-mediated signaling in both murine CF models and patients with CF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593379      PMCID: PMC3111054          DOI: 10.4049/jimmunol.1100396

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Rab7: a key to lysosome biogenesis.

Authors:  C Bucci; P Thomsen; P Nicoziani; J McCarthy; B van Deurs
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

2.  Toll like receptor family (TLT) and signalling pathway.

Authors:  M Muzio; N Polntarutti; D Bosisio; M K Prahladan; A Mantovani
Journal:  Eur Cytokine Netw       Date:  2000-09       Impact factor: 2.737

3.  Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses.

Authors:  Christian Mueller; Sofia A Braag; Allison Keeler; Craig Hodges; Mitchell Drumm; Terence R Flotte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

4.  Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis.

Authors:  C Hubeau; E Puchelle; D Gaillard
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

5.  Regulation of Toll-like receptors in human monocytes and dendritic cells.

Authors:  A Visintin; A Mazzoni; J H Spitzer; D H Wyllie; S K Dower; D M Segal
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

6.  Overexpression of Toll-like receptor 4 amplifies the host response to lipopolysaccharide and provides a survival advantage in transgenic mice.

Authors:  Franck Bihl; Laurent Salez; Magali Beaubier; David Torres; Line Larivière; Line Laroche; Alexandre Benedetto; Dominic Martel; Jean-Martin Lapointe; Bernhard Ryffel; Danielle Malo
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

7.  Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B.

Authors:  Q Jiang; S Akashi; K Miyake; H R Petty
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

8.  Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction.

Authors:  Eicke Latz; Alberto Visintin; Egil Lien; Kate A Fitzgerald; Brian G Monks; Evelyn A Kurt-Jones; Douglas T Golenbock; Terje Espevik
Journal:  J Biol Chem       Date:  2002-09-24       Impact factor: 5.157

9.  Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation.

Authors:  Martha Triantafilou; Kensuke Miyake; Douglas T Golenbock; Kathy Triantafilou
Journal:  J Cell Sci       Date:  2002-06-15       Impact factor: 5.285

Review 10.  State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?

Authors:  James F Chmiel; Pamela B Davis
Journal:  Respir Res       Date:  2003-08-27
View more
  60 in total

1.  Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.

Authors:  Rachel J Fields; Elias Quijano; Nicole Ali McNeer; Christina Caputo; Raman Bahal; Kavi Anandalingam; Marie E Egan; Peter M Glazer; W Mark Saltzman
Journal:  Adv Healthc Mater       Date:  2014-08-25       Impact factor: 9.933

2.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

3.  Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.

Authors:  Jonas C Schupp; Sara Khanal; Jose L Gomez; Maor Sauler; Taylor S Adams; Geoffrey L Chupp; Xiting Yan; Sergio Poli; Yujiao Zhao; Ruth R Montgomery; Ivan O Rosas; Charles S Dela Cruz; Emanuela M Bruscia; Marie E Egan; Naftali Kaminski; Clemente J Britto
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

4.  MD2 expression is reduced in large airways of smokers and COPD smokers.

Authors:  Elisabetta Pace; Maria Ferraro; Giuseppina Chiappara; Patrizio Vitulo; Loredana Pipitone; Serena Di Vincenzo; Mark Gjomarkaj
Journal:  Mol Cell Biochem       Date:  2015-06-12       Impact factor: 3.396

5.  Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa.

Authors:  Roxanna Barnaby; Katja Koeppen; Amanda Nymon; Thomas H Hampton; Brent Berwin; Alix Ashare; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-16       Impact factor: 5.464

6.  Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis.

Authors:  Katherine B Hisert; Kelly Q Schoenfelt; Gordon Cooke; Brenda Grogan; Jan L Launspach; Charles G Gallagher; Seamas C Donnelly; Michael J Welsh; Pradeep K Singh; Edward F McKone; Lev Becker
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

7.  Human Cystic Fibrosis Macrophages Have Defective Calcium-Dependent Protein Kinase C Activation of the NADPH Oxidase, an Effect Augmented by Burkholderia cenocepacia.

Authors:  Kaivon Assani; Chandra L Shrestha; Frank Robledo-Avila; Murugesan V Rajaram; Santiago Partida-Sanchez; Larry S Schlesinger; Benjamin T Kopp
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

8.  The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.

Authors:  Romina Fiorotto; Ambra Villani; Antonis Kourtidis; Roberto Scirpo; Mariangela Amenduni; Peter J Geibel; Massimiliano Cadamuro; Carlo Spirli; Panos Z Anastasiadis; Mario Strazzabosco
Journal:  Hepatology       Date:  2016-10-27       Impact factor: 17.425

9.  Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells.

Authors:  Catriona Kelly; Paul Canning; Paul J Buchanan; Mark T Williams; Vanessa Brown; Dieter C Gruenert; J Stuart Elborn; Madeleine Ennis; Bettina C Schock
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-11       Impact factor: 5.464

10.  Glia maturation factor-γ negatively modulates TLR4 signaling by facilitating TLR4 endocytic trafficking in macrophages.

Authors:  Wulin Aerbajinai; Kevin Lee; Kyung Chin; Griffin P Rodgers
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.